Keri Hurley-Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Keri Hurley-Kim has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Chan
School of Pharmacy & Pharmaceutical Sciences, University of California, Irvine, CA
2 shared publications - Cheryl Wisseh
Department of Clinical Pharmacy Practice, University of California, Irvine, USA
2 shared publications Sarah McBane
University of California Irvine School of Pharmacy and Pharmaceutical Sciences, Irvine, CA, USA
2 shared publications- Aryana Sepassi
University of California, San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences, 9255 Pharmacy Lane, La Jolla, CA 92093, USA
1 shared publication - Ashley Wang
Department of Clinical Pharmacy Practice, School of Pharmacy & Pharmaceutical Sciences University of California Irvine California USA
1 shared publication - Aya Enkoji
University of California, Irvine School of Pharmacy and Pharmaceutical Sciences, 856 Health Sciences Rd, Irvine, CA 92697, USA
1 shared publication
Latest Publications
- Open Access
- 22 August 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 228, 112424
Associations between long-term metformin use, the risk of vitamin B12 deficiency, and neuropathy: An All of Us research Program study
- 22 August 2025
- Published by Elsevier in Diabetes Research and Clinical Practice
- Vol. 228, 112424
Open AccessAssociations between long-term metformin use, the risk of vitamin B12 deficiency, and neuropathy: An All of Us research Program study
- Open Access
- 1 January 2023
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 14
Pharmacist-Managed Refill Service Impacts on Clinician Workload and Medication Interventions in a Federally Qualified Health Center
Introduction: Increasing administrative workload is linked with lower quality of patient care and physician burnout. Conversely, models involving pharmacists can positively impact patient care and physician well-being. Research has consistently demonstrated that pharmacist-physician collaboration can improve outcomes for chronic diagnoses. Pharmacist-managed refill services may improve provider workload measures and clinical outcomes. Methods: This was an evaluation of a pharmacist-managed refill service at a Federally Qualified Health Center (FQHC). Under collaborative practice agreement, pharmacists addressed refill requests and recommended interventions. Data analysis evaluated effectiveness of the model, including clinical interventions, and involved descriptive statistics and qualitative approaches. Results: Average patient age was 55.5 years old and 53.1% were female. Turnaround time was within 48 h for 87.8% of refill encounters. During an average of 3.2 h per week, pharmacists addressed 9.2% (n = 1683 individual requests in 1255 indirect patient encounters) of the total clinic refill requests during the 1-year study period. In 453 of these encounters (36.1%), pharmacists recommended a total of 642 interventions. 64.8% of these were need for appointment (n = 211) or labs (n = 205). Drug therapy problems and medication list discrepancies were identified in 12.6% (n = 81) and 11.9% (n = 76) of encounters, respectively. Discussion and Conclusions: The results of this study are consistent with previous literature demonstrating the value of interprofessional collaboration. Pharmacists addressed refills in an efficient, clinically effective manner in an FQHC setting. This may positively impact primary care provider workload, patients’ medication persistence, and clinical care.
- 1 January 2023
- Published by SAGE Publications in Journal of Primary Care & Community Health
- Vol. 14
Open AccessPharmacist-Managed Refill Service Impacts on Clinician Workload and Medication Interventions in a Federally Qualified Health Center
Introduction: Increasing administrative workload is linked with lower quality of patient care and physician burnout. Conversely, models involving pharmacists can positively impact patient care and physician well-being. Research has consistently demonstrated that pharmacist-physician collaboration can improve outcomes for chronic diagnoses. Pharmacist-managed refill services may improve provider workload measures and clinical outcomes. Methods: This was an evaluation of a pharmacist-managed refill service at a Federally Qualified Health Center (FQHC). Under collaborative practice agreement, pharmacists addressed refill requests and recommended interventions. Data analysis evaluated effectiveness of the model, including clinical interventions, and involved descriptive statistics and qualitative approaches. Results: Average patient age was 55.5 years old and 53.1% were female. Turnaround time was within 48 h for 87.8% of refill encounters. During an average of 3.2 h per week, pharmacists addressed 9.2% (n = 1683 individual requests in 1255 indirect patient encounters) of the total clinic refill requests during the 1-year study period. In 453 of these encounters (36.1%), pharmacists recommended a total of 642 interventions. 64.8% of these were need for appointment (n = 211) or labs (n = 205). Drug therapy problems and medication list discrepancies were identified in 12.6% (n = 81) and 11.9% (n = 76) of encounters, respectively. Discussion and Conclusions: The results of this study are consistent with previous literature demonstrating the value of interprofessional collaboration. Pharmacists addressed refills in an efficient, clinically effective manner in an FQHC setting. This may positively impact primary care provider workload, patients’ medication persistence, and clinical care.
- Open Access
- 13 November 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (2) , 582-591.e20
Sociodemographic characteristics differ across routine adult vaccine cohorts: An All of Us descriptive study
- 13 November 2022
- Published by Elsevier in Journal of the American Pharmacists Association
- Vol. 63 (2) , 582-591.e20
Open AccessSociodemographic characteristics differ across routine adult vaccine cohorts: An All of Us descriptive study
- 9 June 2022
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 5 (8) , 853-864
Worldwide characteristics and trends of pharmacist interventions contributed to minimize health disparities
Health disparities in outcomes are ubiquitous and must be addressed. Pharmacist‐led clinical services have been shown to improve patient outcomes and reduce costs. However, their involvement in addressing health disparities has not been well documented. We conducted a literature review to summarize worldwide pharmacist‐involved interventions that contributed to reducing health disparities. The overarching goal is to provide guidance on future directions to advance health equity. PubMed, Scopus, Embase, and CINAHL were searched from inception to October 2021. Studies included were those that evaluated pharmacist‐involved interventions contributing to the mitigation of health disparities. Pilot or preliminary studies and those published in non‐English languages were excluded. Study characteristics, clinical areas, targeted patient population, types of interventions, and outcomes were evaluated. A total of 151 studies were included, of which 27% were randomized controlled trials. The majority of studies (82%) conducted in high‐income countries targeted cardiometabolic conditions (49%). Infectious diseases were commonly managed conditions among studies (56%) conducted in low‐/middle‐income countries. Most pharmacist‐involved interventions were delivered to rural communities (45%), followed by patients with low income (33%) and racial/ethnic minorities (24%). A minimal number of studies (1%) addressed gender‐ or disability‐related interventions. Multidisciplinary team care (70%) and medication management (64%) were the most prevalent care models reported among the studies, followed by education (49%) and screenings/health fairs (21%). Commonly reported outcome measures included laboratory values (38%), medication utilization (29%), and medication adherence (16%). Only 7% and 9% of the studies reported humanistic and economic outcomes, respectively. Pharmacists have been involved in a variety of clinical interventions targeting a diverse range of patient populations, which unveiled pharmacists' roles in contributing to reducing health disparities. Variability of implemented interventions exists geographically and in certain groups for whom few interventions have been implemented, highlighting the need for further efforts to achieve equity in health care.
- 9 June 2022
- Published by Wiley in JACCP: Journal of the American College of Clinical Pharmacy
- Vol. 5 (8) , 853-864
Worldwide characteristics and trends of pharmacist interventions contributed to minimize health disparities
Health disparities in outcomes are ubiquitous and must be addressed. Pharmacist‐led clinical services have been shown to improve patient outcomes and reduce costs. However, their involvement in addressing health disparities has not been well documented. We conducted a literature review to summarize worldwide pharmacist‐involved interventions that contributed to reducing health disparities. The overarching goal is to provide guidance on future directions to advance health equity. PubMed, Scopus, Embase, and CINAHL were searched from inception to October 2021. Studies included were those that evaluated pharmacist‐involved interventions contributing to the mitigation of health disparities. Pilot or preliminary studies and those published in non‐English languages were excluded. Study characteristics, clinical areas, targeted patient population, types of interventions, and outcomes were evaluated. A total of 151 studies were included, of which 27% were randomized controlled trials. The majority of studies (82%) conducted in high‐income countries targeted cardiometabolic conditions (49%). Infectious diseases were commonly managed conditions among studies (56%) conducted in low‐/middle‐income countries. Most pharmacist‐involved interventions were delivered to rural communities (45%), followed by patients with low income (33%) and racial/ethnic minorities (24%). A minimal number of studies (1%) addressed gender‐ or disability‐related interventions. Multidisciplinary team care (70%) and medication management (64%) were the most prevalent care models reported among the studies, followed by education (49%) and screenings/health fairs (21%). Commonly reported outcome measures included laboratory values (38%), medication utilization (29%), and medication adherence (16%). Only 7% and 9% of the studies reported humanistic and economic outcomes, respectively. Pharmacists have been involved in a variety of clinical interventions targeting a diverse range of patient populations, which unveiled pharmacists' roles in contributing to reducing health disparities. Variability of implemented interventions exists geographically and in certain groups for whom few interventions have been implemented, highlighting the need for further efforts to achieve equity in health care.